Abstract
Optical imaging offers a high potential for noninvasive detection of cancer in humans. Recent advances in instrumentation for diffuse optical imaging have led to new capabilities for the detection of cancer in highly scattering tissue such as the female breast. We review recent developments in the detection of breast cancer in humans by fluorescent contrast agents. So far, the unspecific contrast agents indocyanine green (ICG) and omocyanine have been applied, whereas molecular probes for direct targeted imaging of this disease are still in preclinical research. We discuss recent improvements in the differentiation of malignant and benign lesions with ICG based on its enhanced extravasation in breast cancer. Whereas fluorescence imaging in thick tissue layers is hampered by strong light scattering, tissue surfaces can be investigated with high spatial resolution. As an example for superficial tumors, lesions of the gastrointestinal tract (GI) are discussed. In these investigations, protoporphyrin IX is used as a tumor-specific (due to its strong enhancement in tumor cells) target for spectroscopic identification and imaging. We present a time-gated method for fluorescence imaging and spectroscopy with strong suppression of tissue autofluorescence and show results on patients with Barrett′s esophagus and with colitis ulcerosa.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Baumgartner R, Huber RM, Schulz H et al (1996) Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J Photochem Photobiol, B 36:169–174
Becker A, Hessenius C, Licha K et al (2001) Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nature Biotechnol 19:327–331
Betz CS, Stepp H, Janda P et al (2002) A comparative study of normal inspection, autofluorescence and 5-ALA-induced PPIX fluorescence for oral cancer diagnosis. Int J Cancer 97:245–252
Braun-Falco O, Landthaler M (1990) Das maligne Melanom der Haut. Dt Ärztebl 87:933–936
Bremer C, Ntziachristos V, Weitkamp B et al (2005) Optical imaging of spontaneous breast tumors using protease sensing ‘smart’ optical probes. Invest Radiol 40:321–327
Cauberg EC, de Bruin DM, Faber DJ et al (2009) A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications. Eur Urol 56:287–296
Corlu A, Choe R, Durduran T et al (2007) Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans. Opt Expr 15:6696–6716
Cubeddu R, Pifferi A, Taroni P et al (1999) Fluorescence lifetime imaging: an application to the detection of skin tumors. IEEE J Sel Top Quant Electron 5:923–929
Daldrup-Link HE, Brasch RC (2003) Macromolecular contrast agents for MR mammography: current status. Eur Radiol 13:354–365
Ebert B, Sukowski U, Grosenick D et al (2001) Near-infrared fluorescent dyes for enhanced contrast in optical mammography: phantom experiments. J Biomed Opt 6:134–140
Ebert B, Riefke B, Sukowski U et al. (2011) Cyanine dyes as contrast agents for near-infrared imaging in vivo: acute tolerance, pharmacokinetics, and fluorescence imaging. J Biomed Opt 16:066003-1-9
Enfield LC, Gibson AP, Everdell NL et al (2007) Three-dimensional time-resolved optical mammography of the uncompressed breast. Appl Opt 46:3628–3638
Feng Y, Jeong EK, Mohs AM et al (2008) Characterization of tumor angiogenesis with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice. Magn Reson Med 60:1347–1352
Fischer T, Ebert B, Voigt J et al (2010) Detection of rheumatoid arthritis using non-specific contrast enhanced fluorescence imaging. Acad Radiol 17:375–381
Floery D, Helbich TH, Riedl CC et al (2005) Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience. Invest Radiol 40:328–335
Fusco V, Ebert B, Weber-Eibel J et al (2012) Cancer prevention in ulcerative colitis: long-term outcome following fluorescence-guided colonoscopy. Inflamm Bowel Dis 18:489–495
Grosenick D, Moesta KT, Möller M et al (2005) Time-domain scanning optical mammography: I. recording and assessment of mammograms of 154 patients. Phys Med Biol 50:2429–2449
Grosenick D, Hagen A, Steinkellner O et al (2011) A multichannel time-domain scanning fluorescence mammograph: Performance assessment and first in vivo results. Rev Sci Instrum 82:024302
Hagen A, Grosenick D, Macdonald R et al (2009) Late-fluorescence mammography assesses tumor capillary permeability and differentiates malignant from benign lesions. Opt Expr 17:17016–17033
Hautmann H, Pichler JP, Stepp H et al (2007) In vivo kinetics of inhaled 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in bronchial tissue. Respir Res 8:1–7
Hurlstone DP, Kiesslich R, Thomson M et al (2008) Confocal chromoscopic endomicroscopy is superior to chromoscopy alone for the detection and characterisation of intraepithelial neoplasia in chronic ulcerative colitis. Gut 57:196–204
Intes X, Ripoll J, Chen Y et al (2003) In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green. Med Phys 30:1039–1047
Liebert A, Wabnitz H, Obrig H et al (2006) Non-invasive detection of fluorescence from exogenous chromophores in the adult human brain. Neuroimage 31:600–608
Liu Q, Chen K, Martin M et al (2007) Development of a synchronous fluorescence imaging system and data analysis methods. Opt Express 15:12583–12594
Kemmner W, Wan K, Rüttinger S et al (2008) Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J 22:500–509
Maeda H, Wu J, Sawa T et al (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Controlled Release 65:271–284
Mahmood U (2004) Near infrared optical applications in molecular imaging. Earlier, more accurate assessment of disease presence, disease course, and efficacy of disease treatment. IEEE Eng Med Biol Mag 23:58–66
Moesta KT, Ebert B, Rinneberg H et al (1997) Techniken zur Erkennung minimal residueller Erkrankungen—Fluoreszenzdiagnostik. Der Onkologe 3:422–428
Moesta KT, Ebert B, Handke T et al (2000) Fluorescence as a concept in colorectal lymph node diagnosis. Recent Results Cancer Res 157:293–304
Moesta KT, Ebert B, Handke T et al (2001) Protoporphyrin IX occurs naturally in colorectal cancers and their metastases. Cancer Res 61:991–999
Ntziachristos V, Yodh AG, Schnall M et al (2000) Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci USA 97:2767–2772
Ortner M-AEJ, Ebert B, Hein E et al (2003) Time gated fluorescence spectroscopy in Barrett′s esophagus. Gut 52:28–33
Ortner M-AEJ, Fusco V, Ebert B et al (2010) Time-gated fluorescence spectroscopy improves endoscopic detection of low-grade dysplasia in ulcerative colitis. Gastrointest Endosc 71:312–318
Panjehpour M, Overholt BF, Vo-Dinh T et al (1996) Endoscopic fluorescence detection of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 111:93–101
Perlitz C, Licha K, Scholle FD et al (2005) Comparison of two tricarbocyanine-based dyes for fluorescence optical imaging. J Fluoresc 15:443–454
Poellinger A, Burock S, Grosenick D et al (2011) Breast cancer: early- and late-fluorescence near-infrared imaging with indocyanine green—a preliminary study. Radiology 258:409–416
Richards-Kortum R, Sevick-Muraca E (1996) Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem 47:555–606
Rinneberg H, Grosenick D, Moesta KT et al (2005) Scanning time-domain optical mammography: detection and characterization of breast tumors in vivo. Technol Cancer Res Treat 4:483–496
Rinneberg H, Grosenick D, Moesta KT et al (2008) Detection and characterization of breast tumors by time-domain scanning optical mammography. Opto-Electron Rev 16:147–162
Rubin DT, Rothe JA, Hetzel JT et al (2007) Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc 65:998–1004
Rutter M, Saunders B, Wilkinson K et al (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126:451–459
Taroni P, Torricelli A, Spinelli L et al (2005) Time-resolved optical mammography between 637 and 985 nm: clinical study on the detection and identification of breast lesions. Phys Med Biol 50:2469–2488
Van de Ven S, Wiethoff A, Nielsen T et al (2010) A novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients. Mol Imaging Biol 12:343–348
Wagnieres G, Hadjur C, Grosjean P et al (1998) Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin. Photochem Photobiol 68:382–387
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ebert, B., Grosenick, D. (2013). Optical Imaging of Breast Tumors and of Gastrointestinal Cancer by Laser-Induced Fluorescence. In: Schober, O., Riemann, B. (eds) Molecular Imaging in Oncology. Recent Results in Cancer Research, vol 187. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-10853-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-10853-2_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-10852-5
Online ISBN: 978-3-642-10853-2
eBook Packages: MedicineMedicine (R0)